黑人肾移植受者早期撤减类固醇的比较效果分析
本研究利用美国器官共享联合网络2000至2009年黑人成人肾移植受者数据随访至2014年,经倾向性评分匹配比较早期撤减类固醇与持续使用类固醇各5565例,发现早期撤减组移植物丢失风险相似(HR 0.98),死亡风险较低(HR 0.91),但未接受细胞溶解性诱导、他克莫司和霉酚酸酯或发生移植肾功能延迟恢复者风险较高。
要点
- 黑人肾移植受者早期撤减类固醇与持续使用相比移植物丢失风险相似(HR 0.98,95%CI 0.92-1.04)。
- 早期撤减类固醇组死亡风险较低(HR 0.91,95%CI 0.84-0.99),主要源于移植后4年以上的晚期生存优势。
- 未接受细胞溶解性诱导、他克莫司和霉酚酸酯或发生移植肾功能延迟恢复者,早期撤减与移植物丢失和死亡风险较高相关。
核心结论
- 总体上,黑人肾移植受者早期撤减类固醇与移植物丢失无关,但似乎与更好的长期患者生存相关。
- 未接受细胞溶解性诱导、他克莫司和霉酚酸酯或发生移植肾功能延迟恢复的黑人患者,早期撤减类固醇与移植物丢失和死亡风险较高相关。
研究设计与样本
- 队列研究,使用美国器官共享联合网络数据,纳入2000至2009年所有成人黑人肾移植受者并随访至2014年。
- 采用倾向性评分匹配平衡持续类固醇组与早期撤减类固醇组的基线风险,并用交互项评估早期撤减效果是否随基线和移植后因素变化。
- 26582例合格黑人肾移植受者中5825例(21.9%)接受早期撤减类固醇,5565例早期撤减患者与5565例持续使用类固醇的黑人患者匹配。
主要发现
- 早期撤减类固醇组与持续类固醇组的移植物丢失风险相似(风险比0.98;95%置信区间0.92至1.04;P=0.42)。
- 早期撤减类固醇组死亡风险较低(风险比0.91;95%置信区间0.84至0.99;P=0.02),主要源于移植后4年以上的晚期死亡率优势。
- 移植肾功能延迟恢复、细胞溶解性诱导、他克莫司和霉酚酸酯显著改变早期撤减类固醇对结局的影响(P<0.05)。
- 持续类固醇组急性排斥率略高于早期撤减组(分别为13.0%与11.3%;P<0.01),但与移植物或患者生存无关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: There is continued debate whether early steroid withdrawal is safe to use in high-immunologic risk patients, such as blacks. The goal of this study was to use comparative effectiveness methodology to elucidate the safety of early steroid withdrawal in blacks with kidney transplants. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Our cohort study used United Network of Organ Sharing data including all adult black kidney transplant recipients from 2000 to 2009 followed through 2014. Propensity score matching was used to equalize baseline risk between continued steroid and early steroid withdrawal groups. Interaction terms were used to assess if the effect of early steroid withdrawal on outcomes varied by baseline and post-transplant factors. Of 26,582 eligible black patients with kidney transplants (5825 [21.9%] with early steroid withdrawal), 5565 patients with early steroid withdrawal were matched to 5565 blacks on continued steroid use. RESULTS: Black patients with early steroid withdrawal had similar risk of graft loss (hazard ratio, 0.98; 95% confidence interval, 0.92 to 1.04; P=0.42) and lower risk of death (hazard ratio, 0.91; 95% confidence interval, 0.84 to 0.99; P=0.02), primarily driven by a late mortality advantage (>4 years post-transplant). Delayed graft function, cytolytic induction, tacrolimus, and mycophenolate significantly modified the effect of early steroid withdrawal on outcomes (P<0.05). Acute rejection rates were slightly higher in the continued steroid group (13.0% versus 11.3%, respectively; P<0.01), but this was not associated with graft or patient survival. CONCLUSIONS: Overall, early steroid withdrawal in black kidney transplant recipients was not associated with graft loss but seemed to be associated with better long-term patient survival. Early steroid withdrawal in blacks not receiving cytolytic induction, tacrolimus, and mycophenolate or those with delayed graft function was associated with higher risk of graft loss and death.
引用
- Taber DJ, Hunt KJ, Gebregziabher M, et al. A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients. Clin J Am Soc Nephrol. 2016. PMID: 27979979. doi:10.2215/CJN.04880516
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。